Publications by authors named "Valeria M Ushakova"
Pharmaceuticals (Basel)
April 2022
Article Synopsis
- The LCGA-17 peptide is introduced as a new candidate for treating anxiety and depression, working through specific brain receptors and potentially enhancing GABA-A receptor activity.
- The study tested the effects of acute and chronic intranasal LCGA-17 on stress and anxiety in rats, using various behavioral tests that mimic symptoms of PTSD and depression.
- Results showed significant anxiolytic and antidepressant effects from LCGA-17, outperforming some existing treatments, and it also restored important neurotransmitter levels in the brain post-stress, suggesting its potential for rapid action in mental health treatment.
